Cite
HARVARD Citation
Kammüller, M. et al. (2017). Inhibition of IL‐17A by secukinumab shows no evidence of increased Mycobacterium tuberculosis infections. Clinical & translational immunology. 6 (8), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kammüller, M. et al. (2017). Inhibition of IL‐17A by secukinumab shows no evidence of increased Mycobacterium tuberculosis infections. Clinical & translational immunology. 6 (8), p. n/a. [Online].